UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Celliant Socks to Increase Tissue Oxygenation and Complete Wound Closure in Diabetic Foot Wounds
Not Applicable
Terminated
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Device: Control (placebo) Medical SocksDevice: Celliant Diabetic Medical Socks
- First Posted Date
- 2021-01-14
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT04709419
- Locations
- 🇺🇸
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections.
Phase 4
Terminated
- Conditions
- Urinary Tract Infections
- Interventions
- Drug: Hiprex
- First Posted Date
- 2021-01-14
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT04709601
- Locations
- 🇺🇸
UT-Southwestern Medical Center, Dallas, Texas, United States
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
Phase 4
Recruiting
- Conditions
- Factor VIIIHemophilia A
- Interventions
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT04690322
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
VisionRT-based Deep Inspiration Breath-hold (DIBH) Respiratory Motion Management Strategy, A Pilot Study for Thoracic and Abdominal Tumors
Not Applicable
Completed
- Conditions
- Abdominal CancerThoracic Cancer
- Interventions
- Device: Tidal volume measured by spirometer and DIBH surface from CT image
- First Posted Date
- 2020-12-28
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT04686500
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Exercise Regimens and Neoadjuvant Chemotherapy
Not Applicable
Withdrawn
- Conditions
- Cancer of Gastrointestinal Tract
- Interventions
- Other: In-Person Exercise ProtocolOther: Virtual Exercise Protocol
- First Posted Date
- 2020-12-28
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT04685759
- Locations
- 🇺🇸
UT Southwestern Medical Center, Moncrief Cancer Institute, Fort Worth, Texas, United States
🇺🇸UT Southwestern Simmons Comprehensive Cancer Center - Fort Worth, Fort Worth, Texas, United States
Ultra-fractionated Radiotherapy for Rectal Cancer
Phase 1
Recruiting
- Conditions
- Rectal Cancer
- Interventions
- Radiation: Ultrafractionated radiotherapy for rectal cancer
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 27
- Registration Number
- NCT04677413
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet
Early Phase 1
Not yet recruiting
- Conditions
- Kidney Stone
- Interventions
- Drug: Potassium citrateDrug: Sodium bicarbonateDietary Supplement: LitholyteDietary Supplement: Crystal LiteDrug: Potassium Bicarbonate
- First Posted Date
- 2020-12-03
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT04651088
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Polypill Strategy for Heart Failure With Reduced Ejection Fraction
Early Phase 1
Recruiting
- Conditions
- Heart Failure
- Interventions
- Drug: Control RxDrug: Polypill
- First Posted Date
- 2020-11-17
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 175
- Registration Number
- NCT04633005
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM)
Phase 4
Terminated
- Conditions
- Breast Cancer
- Interventions
- Procedure: Digital MammographyDrug: Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml
- First Posted Date
- 2020-11-12
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 6
- Registration Number
- NCT04625517
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Not Applicable
Recruiting
- Conditions
- Fumarate Hydratase DeficiencyHereditary Leiomyomatosis and Renal Cell CancerClear Cell CarcinomaUrothelial CarcinomaPapillary Renal Cell CarcinomaChromophobe Renal Cell CarcinomaSuccinate Dehydrogenase-Deficient Renal Cell CarcinomaHLRCCKidney CancerRenal Cell Carcinoma
- Interventions
- Other: 13C-FructoseOther: 13C-GlucoseOther: 13C-GlutamineOther: 13C-AcetateOther: 13C-Lactate
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 600
- Registration Number
- NCT04623502
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath